Do I need a Free Androgen Index (FAI) test?
Are you noticing changes in your skin, mood, or energy that might be hormone-related? A Free Androgen Index (FAI) test can help you understand whether androgen activity may be playing a role in what you're experiencing.
The FAI measures the ratio of your total testosterone to sex hormone-binding globulin (SHBG), giving you a clearer picture of how much biologically active testosterone is circulating in your body—something total testosterone alone can't show.
Understanding your FAI may help you make sense of hormonal patterns that influence your metabolism, mood, and reproductive health. It's especially valuable if you're exploring conditions like PCOS or tracking how your hormones shift over time. Knowledge is powerful, and this biomarker is part of Listen Health's comprehensive female health panel, designed to help you stay informed about your wellbeing.
What is it?
The Free Androgen Index (FAI) measures the ratio of total testosterone (TT) to sex hormone-binding globulin (SHBG) and reflects how much biologically active (free) testosterone is circulating in the body. Unlike total testosterone alone, the FAI provides a clearer picture of androgen activity — especially in women, where even small hormonal shifts can influence mood, metabolism, and reproductive health. The FAI is particularly valuable in assessing androgen excess conditions like polycystic ovary syndrome (PCOS), as well as metabolic and cardiovascular risk.
Book Your Test Now
Test Free Androgen Index (FAI) as part of 100+ biomarkers with Listen Health's annual membership.
Start Testing TodayWhy does it matter?
Androgens like testosterone play essential roles in energy, muscle tone, libido, and mood. However, both too much and too little free androgen activity can disrupt health.
Elevated FAI is often linked to PCOS, insulin resistance, and metabolic syndrome, increasing long-term risks of cardiovascular disease and type 2 diabetes.
Low FAI, on the other hand, may contribute to fatigue, low libido, and loss of lean muscle, particularly in women using oral contraceptives or experiencing perimenopause.
Because SHBG fluctuates with metabolic health, liver function, and oestrogen levels, FAI also acts as a metabolic health barometer, not just a hormone marker.
What causes fluctuations?
FAI can shift for several physiological and lifestyle reasons:
Menstrual Cycle: Testosterone and SHBG levels naturally vary during the cycle, influencing FAI.
Age & Menopause: FAI tends to rise with age as SHBG declines, especially after menopause.
Body Composition: Higher body fat and insulin resistance reduce SHBG, raising FAI.
Medications: Oral contraceptives or estrogen therapy increase SHBG, lowering FAI; anabolic steroids or insulin-sensitizing drugs can reduce it.
Liver or Thyroid Health: Since SHBG is produced in the liver and regulated by thyroid hormones, dysfunction in either can shift FAI levels.
Recommendations
If Your FAI Is High:
Address Insulin Resistance: Prioritize blood sugar balance through a low-glycemic, whole-food diet rich in fiber, protein, and omega-3 fats. Avoid refined carbohydrates and excess sugar.
Reduce Androgen Excess Naturally:
Exercise regularly — resistance and aerobic training improve insulin sensitivity and lower androgens.
Support liver detoxification with cruciferous vegetables (broccoli, cauliflower, kale) to aid hormone metabolism.
Medical Support:
Speak with your clinician about testing for PCOS or adrenal overactivity.
In some cases, oral contraceptives, metformin, or anti-androgens (e.g., spironolactone) may be used to regulate hormones.
Lower Stress: Chronic stress elevates cortisol, which can indirectly increase androgen production — mindfulness, sleep, and nervous system regulation help balance both.
If Your FAI Is Low:
Assess SHBG and Estrogen Levels: Elevated SHBG (often from oral contraceptives or high estrogen) can lower free androgens. Discuss with your practitioner if this balance needs adjustment.
Support Hormone Production:
Include healthy fats and cholesterol (eggs, olive oil, avocado, wild-caught fish) to provide building blocks for steroid hormones.
Ensure adequate zinc, magnesium, and vitamin D, which support androgen synthesis.
Address Adrenal or Pituitary Health: Chronic fatigue, low libido, and low mood may signal adrenal or pituitary insufficiency; consider cortisol and DHEA testing.
Review Medications: Oral contraceptives and estrogen therapies can suppress FAI; your clinician can help explore alternatives if symptoms persist.
References
Zhang, D., Gao, J., Liu, X., Qin, H., & Wu, X. (2021). Effect of three androgen indexes (FAI, FT, and TT) on clinical, biochemical, and fertility outcomes in women with polycystic ovary syndrome. Reproductive Sciences, 28(3), 775–784. https://doi.org/10.1007/s43032-020-00316-1
Zhao, W., Li, Z., Cai, B., Zhou, C., & Mai, Q. (2024). Impact of dehydroepiandrosterone sulfate and free androgen index on pregnancy and neonatal outcomes in PCOS patients. Reproductive Biology and Endocrinology, 22(1), 43. https://doi.org/10.1186/s12958-024-01212-y
Bui, H. N., Sluss, P. M., & Hayes, F. J. (2015). Testosterone, free testosterone, and free androgen index in women: Reference intervals, biological variation, and diagnostic value in PCOS. Clinica Chimica Acta, 450, 227–232. https://doi.org/10.1016/j.cca.2015.08.019
Abdalla, M. A., Deshmukh, H., & Mohammed, I. (2021). The effect of free androgen index on quality of life in women with PCOS: A cross-sectional study. Frontiers in Physiology, 12, 652559. https://doi.org/10.3389/fphys.2021.652559
Sutton-Tyrrell, K., Wildman, R. P., & Matthews, K. A. (2005). Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in premenopausal and perimenopausal women. Circulation, 111(10), 1242–1249. https://doi.org/10.1161/01.CIR.0000157697.54255.CE
Rahmatnezhad, L., Moghaddam-Banaem, L., & Behrouzi Lak, T. (2023). Free androgen index relations with oxidative stress and insulin resistance in PCOS. Scientific Reports, 13(1), 5118. https://doi.org/10.1038/s41598-023-31406-0
Elhassan, Y. S., Hawley, J. M., & Cussen, L. (2025). Society for Endocrinology clinical practice guideline for the evaluation of androgen excess in women. Clinical Endocrinology, 103(4), 540–566. https://doi.org/10.1111/cen.15265
Santoro, N., Torrens, J., & Crawford, S. (2005). Correlates of circulating androgens in midlife women: The Study of Women’s Health Across the Nation (SWAN). The Journal of Clinical Endocrinology & Metabolism, 90(8), 4836–4845. https://doi.org/10.1210/jc.2004-2063
Hahn, S., Kuehnel, W., & Tan, S. (2007). Diagnostic value of calculated testosterone indices in the assessment of PCOS.Clinical Chemistry and Laboratory Medicine, 45(2), 202–207. https://doi.org/10.1515/CCLM.2007.031
Frequently Asked Questions
Related Biomarkers
Testosterone, Total
Luteinising Hormone
Progesterone
Thyroglobulin Antibodies
Thyroid-Stimulating Hormone
Thyroid Peroxidase Antibodies
AHPRA Disclaimer: This information is general in nature and should not replace individual medical advice. Always discuss your test results and health concerns with a registered healthcare practitioner.